Leslie L. Iversen, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 30,000 shares at $36.01 ($1.1M) on 2015-11-11, disclosed to the SEC on 2015-11-13.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACAD | SELL | 2013-09-13 | $1.4M | — | Filing → |
| ACAD | BUY | 2009-05-20 | $5K | — | Filing → |